M.J. Perren

1.7k total citations
29 papers, 1.4k citations indexed

About

M.J. Perren is a scholar working on Psychiatry and Mental health, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, M.J. Perren has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Physiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in M.J. Perren's work include Migraine and Headache Studies (10 papers), Neuroendocrine regulation and behavior (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). M.J. Perren is often cited by papers focused on Migraine and Headache Studies (10 papers), Neuroendocrine regulation and behavior (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). M.J. Perren collaborates with scholars based in United Kingdom and United States. M.J. Perren's co-authors include W. Feniuk, P.P.A. Humphrey, Helen E. Connor, Eric T. Whalley, A. W. Oxford, Darko Butina, M. Skingle, I.J.M. Beresford, Andrew D. J. Watts and C. Gardner and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

M.J. Perren

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Perren United Kingdom 19 666 505 388 366 348 29 1.4k
Sara L. Shepheard United Kingdom 15 445 0.7× 326 0.6× 329 0.8× 268 0.7× 284 0.8× 20 980
David Centurión Mexico 22 436 0.7× 498 1.0× 454 1.2× 463 1.3× 286 0.8× 89 1.6k
M. Skingle United Kingdom 19 320 0.5× 517 1.0× 750 1.9× 532 1.5× 147 0.4× 29 1.3k
Roger Marrannes Belgium 15 193 0.3× 127 0.3× 437 1.1× 349 1.0× 92 0.3× 34 1.0k
T. Meert Belgium 20 381 0.6× 462 0.9× 723 1.9× 445 1.2× 40 0.1× 44 1.7k
David Immke United States 13 196 0.3× 547 1.1× 472 1.2× 848 2.3× 104 0.3× 16 1.7k
Levente Szalárdy Hungary 18 314 0.5× 281 0.6× 226 0.6× 433 1.2× 206 0.6× 37 1.4k
Araceli Sánchez‐López Mexico 17 183 0.3× 265 0.5× 251 0.6× 278 0.8× 97 0.3× 62 784
M.K. Shellenberger United States 12 229 0.3× 223 0.4× 503 1.3× 252 0.7× 69 0.2× 18 1.1k
Richard J. Thurlow United Kingdom 8 215 0.3× 502 1.0× 526 1.4× 514 1.4× 43 0.1× 9 1.2k

Countries citing papers authored by M.J. Perren

Since Specialization
Citations

This map shows the geographic impact of M.J. Perren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Perren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Perren more than expected).

Fields of papers citing papers by M.J. Perren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Perren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Perren. The network helps show where M.J. Perren may publish in the future.

Co-authorship network of co-authors of M.J. Perren

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Perren. A scholar is included among the top collaborators of M.J. Perren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Perren. M.J. Perren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Jennifer, Shilina Roman, M.J. Perren, et al.. (2009). Autoradiographical imaging of PPARγ agonist effects on PBR/TSPO binding in TASTPM mice. Experimental Neurology. 216(2). 459–470. 18 indexed citations
2.
Virley, David, M.J. Perren, Mahmoud M. Iravani, et al.. (2008). Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets. Experimental Neurology. 211(1). 172–179. 30 indexed citations
3.
4.
Quinn, Leann P., M.J. Perren, Kim Brackenborough, et al.. (2007). A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(−)-deprenyl. Journal of Neuroscience Methods. 164(1). 43–49. 34 indexed citations
5.
Hows, Mark, Andrew Billinton, M.J. Perren, et al.. (2004). High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates. Journal of Neuroscience Methods. 137(2). 221–226. 17 indexed citations
6.
Wyatt, Paul G., Michael Allen, C. Gardner, et al.. (2002). Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives. Bioorganic & Medicinal Chemistry Letters. 12(10). 1405–1411. 36 indexed citations
7.
Gardner, C. & M.J. Perren. (1998). Inhibition of anaesthetic-induced emesis by a NK1 or 5-HT3 receptor antagonist in the house musk shrew, Suncus murinus. Neuropharmacology. 37(12). 1643–1644. 27 indexed citations
8.
Perren, M.J., et al.. (1997). The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system. Regulatory Peptides. 68(1). 23–29. 31 indexed citations
9.
Barrow, A., et al.. (1997). THE ABSORPTION, PHARMACODYNAMICS, METABOLISM AND EXCRETION OF14C-SUMATRIPTAN FOLLOWING INTRANASAL ADMINISTRATION TO THE BEAGLE DOG. Biopharmaceutics & Drug Disposition. 18(5). 443–458. 4 indexed citations
10.
Perren, M.J., Helen E. Connor, & David T. Beattie. (1996). NK1 and CGRP receptor-mediated dilatation of the carotid arterial bed of the anaesthetized rabbit. Neuropeptides. 30(2). 141–148. 5 indexed citations
11.
Perren, M.J., et al.. (1995). A pharmacological comparison of [3H]-granisetron binding sites in brain and peripheral tissues of the mouse. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(3). 221–8. 9 indexed citations
12.
13.
Feniuk, W., P.P.A. Humphrey, M.J. Perren, Helen E. Connor, & Eric T. Whalley. (1991). Rationale for the use of 5-HT1-like agonists in the treatment of migraine. Journal of Neurology. 238(S1). S57–S61. 50 indexed citations
14.
Humphrey, P.P.A., W. Feniuk, & M.J. Perren. (1990). Anti‐Migraine Drugs in Development: Advances in Serotonin Receptor Pharmacology. Headache The Journal of Head and Face Pain. 30(s1). 12–16. 33 indexed citations
15.
Humphrey, P.P.A., W. Feniuk, M.J. Perren, et al.. (1990). Serotonin and Migraine. Annals of the New York Academy of Sciences. 600(1). 587–598. 192 indexed citations
16.
Perren, M.J., W. Feniuk, & P.P.A. Humphrey. (1989). The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia. 9(9_suppl). 41–46. 65 indexed citations
17.
Humphrey, P.P.A., et al.. (1989). The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.. PubMed. 9 Suppl 9. 23–33. 87 indexed citations
18.
Feniuk, W., P.P.A. Humphrey, & M.J. Perren. (1989). The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. British Journal of Pharmacology. 96(1). 83–90. 118 indexed citations
19.
Humphrey, P.P.A., W. Feniuk, M.J. Perren, et al.. (1988). GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous vein. British Journal of Pharmacology. 94(4). 1123–1132. 253 indexed citations
20.
Humphrey, P.P.A., W. Feniuk, M.J. Perren, et al.. (1987). The Pharmacology Of Selective 5Th1-Like Receptor Agonists For The Acute Treatment Of Migraine. Cephalalgia. 7(6_suppl). 400–401. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara L. Shepheard Breakdown of academic impact, for papers by David Centurión Breakdown of academic impact, for papers by M. Skingle Breakdown of academic impact, for papers by Roger Marrannes Breakdown of academic impact, for papers by T. Meert Breakdown of academic impact, for papers by David Immke Breakdown of academic impact, for papers by Levente Szalárdy Breakdown of academic impact, for papers by Araceli Sánchez‐López Breakdown of academic impact, for papers by M.K. Shellenberger Breakdown of academic impact, for papers by Richard J. Thurlow
Rankless by CCL
2026